AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.65 billion. The enterprise value is $3.45 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 135.91 million shares outstanding. The number of shares has decreased by -0.28% in one year.
| Current Share Class | 135.91M |
| Shares Outstanding | 135.91M |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | -1.29% |
| Owned by Insiders (%) | 8.20% |
| Owned by Institutions (%) | 79.11% |
| Float | 88.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.20 |
| PS Ratio | 0.51 |
| Forward PS | 0.47 |
| PB Ratio | 1.06 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.54 |
| P/OCF Ratio | 2.75 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.88, with an EV/FCF ratio of 15.73.
| EV / Earnings | n/a |
| EV / Sales | 1.06 |
| EV / EBITDA | 5.88 |
| EV / EBIT | 16.87 |
| EV / FCF | 15.73 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.25.
| Current Ratio | 1.02 |
| Quick Ratio | 0.71 |
| Debt / Equity | 1.25 |
| Debt / EBITDA | 2.90 |
| Debt / FCF | 8.67 |
| Interest Coverage | 1.93 |
Financial Efficiency
Return on equity (ROE) is -4.25% and return on invested capital (ROIC) is 6.04%.
| Return on Equity (ROE) | -4.25% |
| Return on Assets (ROA) | 2.90% |
| Return on Invested Capital (ROIC) | 6.04% |
| Return on Capital Employed (ROCE) | 5.68% |
| Weighted Average Cost of Capital (WACC) | 8.16% |
| Revenue Per Employee | $297,693 |
| Profits Per Employee | -$6,495 |
| Employee Count | 10,900 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 17.64 |
Taxes
In the past 12 months, AdaptHealth has paid $50.88 million in taxes.
| Income Tax | 50.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.18% in the last 52 weeks. The beta is 1.50, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +24.18% |
| 50-Day Moving Average | 10.46 |
| 200-Day Moving Average | 9.75 |
| Relative Strength Index (RSI) | 69.01 |
| Average Volume (20 Days) | 1,407,587 |
Short Selling Information
The latest short interest is 9.04 million, so 6.65% of the outstanding shares have been sold short.
| Short Interest | 9.04M |
| Short Previous Month | 7.38M |
| Short % of Shares Out | 6.65% |
| Short % of Float | 10.18% |
| Short Ratio (days to cover) | 5.29 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.24 billion and -$70.79 million in losses. Loss per share was -$0.52.
| Revenue | 3.24B |
| Gross Profit | 677.93M |
| Operating Income | 204.57M |
| Pretax Income | -15.15M |
| Net Income | -70.79M |
| EBITDA | 586.49M |
| EBIT | 204.57M |
| Loss Per Share | -$0.52 |
Full Income StatementBalance Sheet
The company has $106.24 million in cash and $1.90 billion in debt, with a net cash position of -$1.80 billion or -$13.22 per share.
| Cash & Cash Equivalents | 106.24M |
| Total Debt | 1.90B |
| Net Cash | -1.80B |
| Net Cash Per Share | -$13.22 |
| Equity (Book Value) | 1.53B |
| Book Value Per Share | 11.46 |
| Working Capital | 16.51M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $601.77 million and capital expenditures -$382.39 million, giving a free cash flow of $219.38 million.
| Operating Cash Flow | 601.77M |
| Capital Expenditures | -382.39M |
| Depreciation & Amortization | 381.93M |
| Net Borrowing | -268.48M |
| Free Cash Flow | 219.38M |
| FCF Per Share | $1.61 |
Full Cash Flow StatementMargins
Gross margin is 20.89%, with operating and profit margins of 6.30% and -2.18%.
| Gross Margin | 20.89% |
| Operating Margin | 6.30% |
| Pretax Margin | -0.47% |
| Profit Margin | -2.18% |
| EBITDA Margin | 18.07% |
| EBIT Margin | 6.30% |
| FCF Margin | 6.76% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.28% |
| Shareholder Yield | 0.28% |
| Earnings Yield | -4.28% |
| FCF Yield | 13.26% |
Analyst Forecast
The average price target for AdaptHealth is $13.25, which is 8.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.25 |
| Price Target Difference | 8.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 0.98 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.98 |
| Piotroski F-Score | 5 |
